Pediatric chronic Rhinosinusitis is one of the major and common disorder among infants with significant morbidity. Its diagnosis involves sinus symptoms, with prolonged duration requiring standard medical therapy for more than 90 days. The main causative factors for pediatric chronic rhinosinusitis include viral attack, allergic reactions, and physical changes in children leading to chronic obstruction.
This report contains market size and forecasts of Pediatric Chronic Rhinosinusitis Treatment in Global, including the following market information:
Global Pediatric Chronic Rhinosinusitis Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Pediatric Chronic Rhinosinusitis Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Steroids Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Pediatric Chronic Rhinosinusitis Treatment include Pfizer, Bayer, Novartis, Sanofi, AstraZeneca, Teva Pharmaceutical, Sumitomo Dainippon Pharma, Cipla and Lyra Therapeutics. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Pediatric Chronic Rhinosinusitis Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pediatric Chronic Rhinosinusitis Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Pediatric Chronic Rhinosinusitis Treatment Market Segment Percentages, by Type, 2021 (%)
Steroids
Antibiotics
Antifungal Therapy
Others
Global Pediatric Chronic Rhinosinusitis Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Pediatric Chronic Rhinosinusitis Treatment Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Pediatric Chronic Rhinosinusitis Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Pediatric Chronic Rhinosinusitis Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pediatric Chronic Rhinosinusitis Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Pediatric Chronic Rhinosinusitis Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Bayer
Novartis
Sanofi
AstraZeneca
Teva Pharmaceutical
Sumitomo Dainippon Pharma
Cipla
Lyra Therapeutics